ArticleEuropean journal of haematology2019

The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.

Colm Keane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.